GlassScriptPhysician profile
Jeffrey F Bleakley
NPI 1265475040
$4,522.74
in general payments reported to CMS, 2019-2025
19 companies · $470 in 2025
The $470 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,305 · 2020: $130 · 2021: $410 · 2022: $943 · 2023: $364 · 2024: $901 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,453 · Long Term Medical Supply Or Device Loan: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,453.26 |
| Long Term Medical Supply Or Device Loan | $281.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,222.83 | 2019-2020 | |
| Medtronic, INC. | $844.81 | 2021-2025 | Corevalve Evolut R |
| Abbott Laboratories | $599.96 | 2020-2025 | Portico, Amplatzer Amulet, Aveir |
| Shockwave Medical, INC | $517.24 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $275.91 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Edwards Lifesciences Corporation | $186.39 | 2019-2025 | Pascal |
| Boston Scientific Corporation | $169.77 | 2024 | |
| Novartis Pharmaceuticals Corporation | $148.49 | 2024-2025 | |
| Stryker Corporation | $139.21 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cordis US Corp. | $89.68 | 2021 | |
| Abiomed | $68.55 | 2022-2024 | Impella |
| Opsens INC. | $66.75 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $50.56 | 2019-2024 | Wainua |
| Janssen Pharmaceuticals, INC | $42.50 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $28.79 | 2025 | Camzyos |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ekos Corporation | $20.32 | 2019 | |
| Amarin Pharma, INC. | $18.92 | 2021 | |
| Pfizer INC. | $17.05 | 2025 | |
| Siemens Medical Solutions USA, INC. | $15.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Bleakley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.